Andrew Young

Founder at

Phoundry Pharmaceuticals, Inc.

73 year

13 connections

Health Technology

Consumer Services

Government

Profile

Andrew Young is the founder of Satiogen Pharmaceuticals, Inc. (founded in 2007) and Phoundry Pharmaceuticals, Inc. (founded in 2015, where he also holds the title of Director & Chief Scientific Officer).
He previously worked as Vice President-Research at Amylin Pharmaceuticals, Inc., as a Professor-Physiology Department at Auckland University, and as a Clinical Research Scientist at the National Institutes of Health from 1984 to 1987.
Dr. Young received his graduate and doctorate degrees from Auckland University.

Andrew Young active positions

Companies	Position	Start
Phoundry Pharmaceuticals, Inc. Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery of peptide therapeutics	Founder	01/01/2015

All active positions of Andrew Young

Former positions of Andrew Young

Companies	Position	End
National Institutes of Health National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives	Chief Tech/Sci/R&D Officer	01/01/1987
Satiogen Pharmaceuticals, Inc. Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity	Founder	-
Auckland University Auckland University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases	Chief Tech/Sci/R&D Officer	-

See the detail of Andrew Young's experience

Training of Andrew Young

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Young's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases	Health Technology
Auckland University Auckland University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
National Institutes of Health National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives	Government
Satiogen Pharmaceuticals, Inc. Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity	Commercial Services
Phoundry Pharmaceuticals, Inc. Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery of peptide therapeutics	Health Technology